as on February 12, 2026 at 7:59 am IST
Day's Low
Day's High
0.59%
Downside
2.99%
Upside
52 Week's Low
52 Week's High
17.74%
Downside
51.81%
Upside
Check Haemonetics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.3B
EPS (TTM)
4.9141
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.28%
PE Ratio (TTM)
19.99
Industry PE ratio
5.259038461538461
PEG Ratio
1.0454
EBITDA
364.9M
Revenue (TTM)
1.3B
Profit Margin
12.67%
Return On Equity TTM
19.47%
Track how Haemonetics Corp P/E has moved over time to understand its valuation trends.
Haemonetics Corp in the last 5 years
Lowest (13.66x)
December 31, 2025
Industry (5.26x)
February 12, 2026
Today (19.99x)
February 12, 2026
Highest (52.66x)
March 31, 2021
Today’s Price to Earnings Ratio: 19.99x
Compare market cap, revenue, PE, and other key metrics of Haemonetics Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.3B | -57.34% | 19.99 | 12.67% | |
| BUY | $138.7B | 91.38% | 50.03 | 14.43% | |
| BUY | $136.5B | 46.56% | 46.97 | 12.07% | |
| BUY | $129.1B | -15.58% | 27.28 | 13.71% | |
| BUY | $189.3B | -11.42% | 29.24 | 14.72% |
The Haemonetics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Haemonetics Corp investment value today
Current value as on today
₹98,246
Returns
Returns from Haemonetics Corp Stock
Dollar Returns*
₹4,428 (+4.43%)
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Haemonetics Corp. Average target price of $88
Get share price movements and forecasts by analysts on Haemonetics Corp.
What analysts predicted
34.64%UPSIDE
Target Price
$88
Current Price
$57.52
Analyzed by
11 Analysts
Target
$88.00
Haemonetics Corp target price $88, a slight upside of 34.64% compared to current price of $57.52. According to 11 analysts rating.
Search interest for Haemonetics Corp Stock has increased by 80% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:80% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 321.39M → 338.96M (in $), with an average increase of 2.6% per quarter
Profit Spike
![]()
Netprofit is up for the last 3 quarters, 34.03M → 44.74M (in $), with an average increase of 12.8% per quarter
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 21.2% return, outperforming this stock by 47.4%
Against Peers
![]()
In the last 1 year, Medtronic Plc has given 11.0% return, outperforming this stock by 14.0%
Price Dip
![]()
In the last 7 days, HAE stock has moved down by -8.6%
| Organisation | Haemonetics Corp |
| Headquarters | 125 Summer Street, Boston, MA, United States, 02110 |
| Industry | Health Technology |
| CEO | Mr. Christopher A. Simon |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Christopher A. Simon | CEO, President & Director |
Ms. Michelle L. Basil Esq., J.D. | Executive VP, General Counsel & Secretary |
Ms. Farris Maryanne Maunsell | VP, Chief Accounting Officer & Principal Accounting Officer |
Mr. Rajeev Varma | Senior Vice President of Strategy & Corporate Development |
Ms. Laurie A. Miller | Senior VP & Chief Human Resources Officer |
Mr. James C. D'Arecca CPA | CFO, Executive VP & Financial Officer |
Mr. Roy Galvin | Executive VP & Chief Commercial Officer |
Mr. Frank W. Chan Ph.D. | Executive VP & COO |
Ms. Olga Guyette | Senior Director of Investor Relations |
Dr. Jan Hartmann M.D. | Senior VP & Chief Medical Officer |
Haemonetics Corp share price today is $57.52 as on at the close of the market. Haemonetics Corp share today touched a day high of $59.24 and a low of $57.18.
Haemonetics Corp share touched a 52 week high of $87.32 on and a 52 week low of $47.32 on . Haemonetics Corp stock price today i.e. is closed at $57.52,which is 34.13% down from its 52 week high and 21.57% up from its 52 week low.
Haemonetics Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Haemonetics Corp (HAE) shares with as little as ₹90.637 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.37 in Haemonetics Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Haemonetics Corp share’s latest price of $57.52 as on February 12, 2026 at 2:29 am IST, you will get 0.1739 shares of Haemonetics Corp. Learn more about
fractional shares .
Haemonetics Corp stock has given -57.34% share price returns and 24.82% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?